So, there is a novel role of both PAX3-FOXO1 and its downstream effector miR-486-5p in exosome-mediated oncogenic paracrine effects of RMS, making it an attractive biomarker in the metastasis and prognosis of rhabdomyosarcoma [116]. Here, PAX3 is linked to rhabdomyosarcoma.